The blue light glasses market exceeds $20 million in annual revenue and is growing. The premise: exposure to short-wavelength light from screens in the evening suppresses melatonin, delays circadian phase, and degrades sleep — and filtering out the blue wavelengths through tinted lenses prevents the effect. The premise is partly supported by laboratory research and partly contradicted by real-world studies. The product category has run ahead of what the evidence can carry.
The original findings
The case begins with sound science. The work of George Brainard, Charles Czeisler, and others established in the early 2000s that light in the 460–480 nanometre range (blue) is particularly effective at suppressing melatonin secretion when administered in the evening. The mechanism is the intrinsically photosensitive retinal ganglion cell (ipRGC), which responds preferentially to short-wavelength light and feeds directly into the suprachiasmatic nucleus — the body's central circadian clock.
Under laboratory conditions, controlled exposure to bright blue light at night produces measurable melatonin suppression and circadian phase delay. The findings are robust. They form the basis for the entire popular discourse around blue light and sleep.
The leap that does not survive scrutiny is from "controlled exposure to bright blue light produces effects in the lab" to "ordinary screen exposure in the evening is a major sleep disruptor that warrants specialised eyewear."
What screen exposure actually produces
Two factors reduce the real-world effect substantially.
The intensity of typical screen exposure is far lower than the laboratory protocols. The studies that produced the dramatic melatonin suppression findings used light intensities of several hundred to several thousand lux delivered directly to the eyes. A typical screen at typical viewing distance delivers tens of lux to the eyes — perhaps 10–50, depending on screen brightness and ambient conditions. The dose-response curve for melatonin suppression is not linear, and the intensities involved in normal screen use are typically well below the range that produced the dramatic lab effects.
The duration and timing windows differ. Most lab studies used hours of continuous evening exposure starting at specific timing relative to dim-light melatonin onset. Typical screen use is variable in timing, often happens across mixed lighting environments, and often involves brief glances rather than fixed staring.
The aggregate effect: short, dim screen exposure in an otherwise lit room produces measurable but small melatonin suppression. The effect is not zero, but it is much smaller than the original lab findings would suggest if naively scaled up.
The RCT evidence on blue light glasses
This is the part that tends not to make it into the marketing.
Several randomised controlled trials and meta-analyses of blue-light-filtering glasses have now been published, including a 2021 systematic review in the Cochrane Database and a 2023 meta-analysis in Ophthalmic and Physiological Optics. The findings are consistent: blue-blocking glasses produce negligible to no measurable effects on sleep onset, sleep duration, sleep quality, or daytime alertness in healthy adults using screens normally. The effects on eye strain and digital eye discomfort are similarly minimal. The placebo arms in these trials typically perform as well as the active arms.
A small effect persists in subgroups with severe evening exposure — extreme cases of bright-screen use late at night in dark rooms — but this is a narrow population. For most users, the glasses are doing essentially nothing.
What does matter
The interventions that show measurable effects on sleep and circadian function, in order of supporting evidence:
- Timing of bright light exposure during the day. Bright outdoor light in the morning is the strongest evidenced intervention for circadian stability. Indoor light, even bright indoor light, does not substitute.
- Reduced ambient lighting in the hour before bed. Lowering overall light levels in the bedroom and surrounding rooms has a larger measurable effect on melatonin than filtering screen wavelengths specifically.
- Consistent sleep timing. Variability in wake time is a stronger circadian disruptor than evening blue light.
- Avoiding screen use in bed. This is partly about light but largely about the cognitive activation produced by interactive media — checking email, scrolling social feeds — that screen use enables.
None of these requires a product purchase, which is part of why they receive less marketing attention.
The defensible remaining case
There is one population for which blue-blocking glasses have a more defensible case: people who work bright screens late into the night under dim ambient lighting — night-shift workers, late-night gamers, evening coders. For these users, the absolute light dose is higher, the relevant darkness is greater, and the marginal effect of filtering may be measurable. Even here, ambient room lighting and screen brightness reduction probably produce larger effects than glasses, and the higher-tier orange-tint and red-tint lenses produce larger effects than the modest "computer glasses" sold in pharmacies.
For the typical knowledge worker checking email at 9pm with the bedroom lamp on, the case is much weaker. The intervention is treating a small problem with a solution that is mostly placebo and a little theatre.
A practical position
For someone trying to apply the evidence:
- Get bright outdoor light in the morning. This is the most important circadian intervention available.
- Dim ambient lights an hour before bed. Lower the overall light level rather than worrying about wavelength.
- Reduce screen brightness in the evening. The system-level "Night Shift" or "Reading Mode" settings already do this and are evidenced as well as anything else for incidental users.
- Avoid screen use in bed itself, for reasons that go beyond light.
- Keep blue light glasses for the narrow population where the dosing actually warrants them, which is not most people.
"When the studies say one thing and the marketing says another, the marketing is what gets repeated." — paraphrased from working sleep researchers.
The blue light glasses category is a clean example of a real laboratory finding being extended commercially well past the population and exposure conditions where the finding actually applies. The science is real. The product is mostly not what the science is about.
